NDC 73309-016 - Rifabutin

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 73309-016
Package NDCs from labels: 73309-016-01
Manufacturer: BLUEBAY SHANDONG CO.,LTD
Effective date: 2019-08-19
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
Rifabutin - BLUEBAY SHANDONG CO.,LTD	BLUEBAY SHANDONG CO.,LTD	2019-08-19	BULK INGREDIENT

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
73309-016-01	Rifabutin	50 g in 1 JAR	POWDER	50		1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
73309-016	RIFABUTIN POWDER [BLUEBAY SHANDONG CO.,LTD]	1	1 package rows	20190822_1b8fbf0d-9095-441d-8cc4-dc6973986ac1.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 6 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Rifabutin	RIFABUTIN	REMEDYREPACK INC.	25a60937-cbbe-4a50-994f-2ce15203f589	2026-09-01	Warnings, Adverse reactions	Exact identifier unii: 1W306TDA6S
Rifabutin	RIFABUTIN	Mylan Pharmaceuticals Inc.	c2026b67-4755-4236-96b6-a6b5e7399707	2026-07-20	Warnings, Adverse reactions	Exact identifier unii: 1W306TDA6S
Rifabutin	RIFABUTIN	REMEDYREPACK INC.	754d2d7f-f0db-4f89-8fcd-5e2ff52d5030	2026-06-05	Warnings, Adverse reactions	Exact identifier unii: 1W306TDA6S
Rifabutin	RIFABUTIN	i3 Pharmaceuticals, LLC	fd6062e2-17c8-48f4-a1fe-69ebe410f583	2026-02-20	Warnings, Adverse reactions	Exact identifier unii: 1W306TDA6S
Talicia	OMEPRAZOLE MAGNESIUM, AMOXICILLIN AND RIFABUTIN	RedHill Biopharma Ltd	68c4e9dc-dbcf-4151-b6f7-5e4b9922b76f	2025-12-23	Warnings, Adverse reactions	Exact identifier unii: 1W306TDA6S
Rifabutin	RIFABUTIN	Marlex Pharmaceuticals, Inc.	df7d4103-42e4-4e4f-e053-2a95a90a8ce8	2025-11-18	Warnings, Adverse reactions	Exact identifier unii: 1W306TDA6S

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.